Stevens-Johnson syndrome (SJS) typically lasts 2 to 4 weeks from the first skin symptoms through complete healing, though the full experience from earliest warning signs to recovered skin can stretch to 6 weeks or more. The timeline depends on how much skin is affected, whether complications develop, and how quickly treatment begins. For many survivors, certain effects like skin discoloration, eye problems, or scarring can linger for months or even become permanent.
The Prodromal Phase: Days 1 to 3
Before any rash appears, SJS begins with 1 to 3 days of flu-like symptoms. You may notice fever, fatigue, a sore mouth and throat, and burning eyes. These symptoms are easy to mistake for a cold or flu, which is part of what makes early diagnosis so difficult. This phase starts anywhere from a few days to 8 weeks after beginning the medication that triggered the reaction, though most cases develop within the first 4 weeks of a new drug.
If you’ve had SJS before and are re-exposed to the same trigger, symptoms can appear within hours rather than days.
The Acute Phase: Weeks 1 to 2
The acute phase is the most dangerous period. It begins when skin lesions appear and the outer layer of skin starts to detach from the layers beneath it. This detachment progresses for about 5 to 7 days before reaching a plateau. During this window, painful blisters and raw, exposed areas develop on the skin and mucous membranes, including the mouth, eyes, and genitals.
SJS is classified by how much body surface area loses its outer skin layer. Less than 10% qualifies as SJS. Between 10% and 30% is considered SJS/TEN overlap, and 30% or more is classified as toxic epidermal necrolysis (TEN), the most severe form. The more skin involved, the longer and more complicated recovery becomes.
Most patients are hospitalized during this phase, often in a burn unit or intensive care unit. The skin essentially functions like a burn wound, leaving the body vulnerable to infection, fluid loss, and temperature regulation problems. Getting admitted promptly matters: delays of 5 days or more before reaching specialized care have been linked to higher rates of infection, ICU admission, and death.
Re-Epithelialization: Weeks 2 to 4
Once skin detachment stops progressing, the body begins rebuilding. New skin cells are recruited from hair follicles and healthy surrounding tissue, and regrowth is generally complete within about 3 weeks of that plateau point. Skin grafting is not typically needed because the deeper skin layers remain intact and can regenerate on their own.
Healing is slower in areas where skin stays moist, experiences pressure (like the back or buttocks in a bedridden patient), or develops infection. Mucous membranes in the mouth, throat, and genitals often take longer to heal than external skin. During this phase, pain management and wound care are the primary focus.
How Serious Is SJS?
SJS carries real mortality risk. In a study of 150 patients treated between 2019 and 2024, the overall death rate was 18.7%. Broken down by severity, roughly 9% of SJS patients died compared to about 27% of those with TEN. Patients with TEN had nearly four times the odds of dying compared to those with SJS alone.
Doctors use a scoring system based on seven factors to predict outcomes: age over 40, presence of cancer, rapid heart rate, the initial percentage of skin affected, and certain blood markers. A higher score correlates with greater risk of a poor outcome.
Eye Involvement and Its Timeline
The eyes are one of the most vulnerable areas during SJS, and the treatment window is narrow. Inflammation and ulceration of the eye surface can begin during the acute phase, and damage that occurs in the first week can become irreversible if not treated aggressively. Specialized eye exams within the first 24 hours of hospital admission, followed by daily monitoring for at least the first week, are considered critical.
If the eye surface is treated early, outcomes improve substantially. But each missed day during that first week represents a lost opportunity to prevent permanent scarring of the cornea, dry eye syndrome, or vision loss. These complications can require ongoing treatment for years.
Long-Term Effects After the Skin Heals
Even after the skin has fully regrown and hospital discharge has happened, SJS is not necessarily over. The chronic phase generally begins 3 to 6 months after the acute episode, once surface inflammation stabilizes. During this period, survivors may deal with a range of lingering or permanent issues.
Skin changes are common: irregular pigmentation (patches that are darker or lighter than surrounding skin), scarring, and sensitivity to sunlight. Nail abnormalities, including ridging or loss, can persist for months. Mucous membrane scarring may cause ongoing problems with dry mouth, dental issues, or genital adhesions.
Eye complications are the most significant long-term concern. Chronic dry eye, light sensitivity, corneal scarring, and in severe cases, progressive vision loss can develop months to years after the initial episode. There is no clean cutoff point at which SJS can be considered fully resolved for the eyes. Some patients require lubricating drops, specialized contact lenses, or surgical procedures indefinitely.
Psychological effects also deserve mention. Many survivors report anxiety about taking new medications, post-traumatic stress, and depression related to scarring or vision changes. These effects have no set endpoint and often benefit from professional support.
Timeline Summary
- Drug exposure to first symptoms: a few days to 8 weeks
- Prodromal (flu-like) phase: 1 to 3 days
- Active skin detachment: 5 to 7 days
- Skin regrowth: approximately 3 weeks after detachment stops
- Total acute illness: roughly 2 to 6 weeks
- Chronic phase onset: 3 to 6 months after the acute episode
- Long-term complications: months to years, sometimes permanent